TickerFacts.

Atea Pharmaceuticals, Inc. (AVIR): Net Income

Annual figures by period end, from SEC filings.

-$158.35M
Year ended 2025-12-31
-$165.29M
Trailing 12 months to 2026-06-30
$121.19M2018-12-31: -$9.06M2019-12-31: -$14.03M2020-12-31: -$10.95M2021-12-31: $121.19M2022-12-31: -$115.91M2023-12-31: -$135.96M2024-12-31: -$168.38M2025-12-31: -$158.35M-$158.35M
2018-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$158.35Mn/m2026-03-05, From 2025-01-01
2024-12-31-$168.38Mn/m2026-03-05, From 2024-01-01
2023-12-31-$135.96Mn/m2025-03-06, From 2023-01-01
2022-12-31-$115.91Mn/m2024-02-28, From 2022-01-01
2021-12-31$121.19Mn/m2023-02-28, From 2021-01-01
2020-12-31-$10.95Mn/m2023-02-28, From 2020-01-01
2019-12-31-$14.03Mn/m2022-02-28, From 2019-01-01
2018-12-31-$9.06Mn/a2021-03-30, From 2018-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Atea Pharmaceuticals, Inc. (AVIR)2025-12-31-$158.35Mn/m
LB Pharmaceuticals Inc (LBRX)2025-12-31-$25.20Mn/m
ADC Therapeutics SA (ADCT)2025-12-31-$142.62Mn/m
Omeros Corp (OMER)2025-12-31-$3.35Mn/m
Sionna Therapeutics, Inc. (SION)2025-12-31-$75.27Mn/m
Prothena Corp Public Ltd Co (PRTA)2025-12-31-$244.09Mn/m
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31-$171.30Mn/m
Liquidia Corp (LQDA)2025-12-31-$68.92Mn/m
Rocket Pharmaceuticals, Inc. (RCKT)2025-12-31-$223.12Mn/m

Compare AVIR, LBRX, ADCT, OMER side by side · Screen every company in Pharmaceutical Preparations ↗